Filing Details
- Accession Number:
- 0001181431-13-048225
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-09 16:09:20
- Reporting Period:
- 2013-09-05
- Filing Date:
- 2013-09-09
- Accepted Time:
- 2013-09-09 16:09:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1158895 | Lemaitre Vascular Inc | LMAT | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1365733 | Jr P Joseph Pellegrino | C/O Lemaitre Vascular, Inc. 63 Second Avenue Burlington MA 01803 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-09-05 | 1,533 | $6.97 | 50,742 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2013-09-05 | 25,000 | $5.95 | 75,742 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-09-05 | 25,000 | $6.86 | 50,742 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-09-05 | 25,000 | $0.00 | 25,000 | $5.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2007-11-21 | 2013-11-21 | No | 4 | M | Direct |
Footnotes
- These shares represent shares withheld to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on September 5, 2008. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
- The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $6.83 to $6.92. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
- This option is fully vested and exercisable.
Billionaire Hedge Funds
